Home/Filings/4/0001053369-16-000038
4//SEC Filing

ELITE PHARMACEUTICALS INC /NV/ 4

Accession 0001053369-16-000038

$ELTPCIK 0001053369operating

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 6:56 PM ET

Size

5.1 KB

Accession

0001053369-16-000038

Insider Transaction Report

Form 4
Period: 2016-02-16
Ward Carter Julian
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2016-02-16$0.25/sh+122,325$29,9941,085,618 total
Holdings
  • Common Stock

    (indirect: By IRA)
    1,355,014

Issuer

ELITE PHARMACEUTICALS INC /NV/

CIK 0001053369

Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0001053369

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 6:56 PM ET
Size
5.1 KB